Haemovigilance in a general university hospital: Need for a more comprehensive classification and a codification of transfusion-related events

Vox Sanguinis

Volumn 88, Issue 1, 2005, Pages 22-30

  Siegenthaler, M A ^a   Schneider, P ^a   Vu, D H ^a   Tissot, J D ^a  

^a Service Regional Vaudois de Transfusion Sanguine   (Switzerland)

Author keywords

Classification; Error; Haemovigilance; Transfusion; Transfusion reaction; Transfusion related event

Indexed keywords

ARTICLE; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; HEALTH CARE QUALITY; HUMAN; MAJOR CLINICAL STUDY; MEDICAL DOCUMENTATION; PATIENT CODING; PRIORITY JOURNAL; THERAPEUTIC ERROR; UNIVERSITY HOSPITAL; ALERTNESS; ALLERGY; ALLOIMMUNIZATION; BACTERIAL INFECTION; BACTERIUM CONTAMINATION; BLOOD ANALYSIS; CONTROLLED STUDY; ERYTHROCYTE CONCENTRATE; FEVER; HEMOSIDEROSIS; HYPERVOLEMIA; METABOLIC DISORDER; TRANSFUSION RELATED ACUTE LUNG INJURY; VIRUS INFECTION;

BACTERIAL INFECTIONS; BLOOD COMPONENT TRANSFUSION; BLOOD TRANSFUSION; CLASSIFICATION; DATA COLLECTION; FEVER; FORMS AND RECORDS CONTROL; HOSPITALS, UNIVERSITY; HUMANS; HYPERSENSITIVITY; ISOANTIBODIES; MEDICAL ERRORS; RETROSPECTIVE STUDIES; RISK MANAGEMENT;

FRESH FROZEN PLASMA; THROMBOCYTE CONCENTRATE;

EID: 13444250958     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2005.00559.x     Document Type: Article

References (25)

1. Mcclelland B, Love E, Scott S, Williamson LM: Haemovigilance: concept, Europe and UK initiatives. Vox Sang 1998; 74:431-439
2. Engelfriet CP, Reesink HW: Haemovigilance systems. Vox Sang 1999; 77:110-111
3. Williamson LM: Haemovigilance systems. Vox Sang 1999; 77:112
4. Williamson LM, Lowe S, Love EM, Cohen H, Soldan K, Mcclelland DBL, Skacel P, Barbara JAJ: Serious hazards of transfusion (SHOT) initiative: analysis of the first two annual reports. Br Med J 1999; 319:16-19
5. Frere MC, Rapaille A, Bouillenne C, Gerard C, Sondag D, Verhees A: Analyse de 516 rapports de réaction après transfusion de produits sanguins labiles. Transfus Clin Biol 2001; 8:333-342
6. Faber JC: Haemovigilance around the world. Vox Sang 2002; 83:71-76
7. Rouger P, Noizat-Pirenne F, Le Pennec PY: Haemovigilance and transfusion safety in France. Vox Sang 2000; 78:287-289
8. Andreu G, Morel P, Forestier F, Debeir J, Rebibo D, Janvier G, Herve P: Hemovigilance network in France: organization and analysis of immediate transfusion incident reports from 1994 to 1998. Transfusion 1994; 42:1356-1364
9. Williamson LM: Using haemovigilance data to set blood safety priorities. Vox Sang 2002; 83:65-69
10. Kleinman S, Chan P, Robillard P: Risks associated with transfusion of cellular blood components in Canada. Transfus Med Rev 2003;17:120-162
11. Michlig C, Vu DH, Wasserfallen JB, Spahn DR, Schneider P, Tissot JD: Three years of haemovigilance in a general University hospital. Transfus Med 2003; 13:63-72
12. Perez P, Salmi LR, Folléa G, Schmit JL, De Barbeyrac B, Sudre P, Salamon R, BACTHEM Grp FH: Determinants of transfusion-associated bacterial contamination: results of the French BACTHEM Case-Control Study. Transfusion 2001; 41:862-872
13. Hillyer CD, Josephson CD, Blajchman MA, Vostal JG, Epstein JS, Goodman JL: Bacterial contamination of blood components. Risks, strategies, and regulation: joint ASH and AABB educational session in transfusion medicine. Hematology (Am Soc Hematol Educ Program) 2003:575-589
14. Wasserfallen JB, Droz PO, Tissot JD: La gestion des risques en milieu hospitalier: exigences et implications. Rev Med Suisse Romande 2001; 121:795-799
15. Tissot JD, Hochstrasser DF, Schneider B, Morgenthaler JJ, Schneider P: No evidence for protein modifications in fresh frozen plasma after photochemical treatment: an analysis by high-resolution two-dimensional electrophoresis. Br J Haematol 1994; 86:143-146
16. David B: Bilan et perspectives du fonctionnement de l'hé movigilance française et des données recueillies sur 9 ans. Transfus Clin Biol 2003; 10:131-139
17. Yazer MH, Podlosky L, Clarke G, Nahirniak SM: The effect of prestorage WBC reduction on the rates of febrile nonhemolytic transfusion reactions to platelet concentrates and RBC. Transfusion 2004; 44:10-15
18. Engelfriet CP, Reesink HW, Brand A, Palfi M, Popovsky MA, Martin-Vega C, Ribera A, Rouger P, Goldman M, Decary F, Freedman J, Lucas G, Navarette C, Neppert J, Witzleben-Schurholz E, Lin M, Zupanska B: Transfusion-related acute lung injury (TRALl). Vox Sang 2001; 81:269-283
19. Silliman CC, Boshkov LK, Mehdizadehkashi Z, Elzi DJ, Dickey WO, Podlosky L, Clarke G, Ambruso DR: Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors. Blood 2003; 101:454-462
20. Kaplan HS, Battles JB, Van der Schaaf TW, Shea CE, Mercer SQ: Identification and classification of the causes of events in transfusion medicine. Transfusion 1998; 38:1071-1081
21. Callum JL, Kaplan HS, Merkley LL, Pinkerton PH, Rabin FB, Romans RA, Coovadia AS, Reis MD: Reporting of near-miss events for transfusion medicine: improving transfusion safety. Transfusion 2001; 41:1204-1211
22. Dzik WH, Murphy MF, Andreu G, Heddle N, Hogman C, Kekomaki R, Murphy S, Shimizu M, Smit-Sibinga CT: An international study of the performance of sample collection from patients. Vox Sang 2003; 85:40-47
23. Chiaroni J, Legrand D, Dettori I, Ferrera V: Analysis of ABO discrepancies occurring in 35 French hospitals. Transfusion 2004; 44:860-864
24. Siegenthaler MA, Vu DH, Ebnother M, Ketterer N, Luthi F, Schmid P, Bargetzi M, Gasparini D, Tissot JD: 'Agglutination and flocculation' of stem cells collected by apheresis due to cryofibrinogen. Bone Marrow Transplant 2004; 33:765-767
25. Munk C, Schwabe R, Lévy G: ISBT 128: the implementation project of the Swiss Red Cross blood transfusion service. Blood Banking Transfus Merf 2003; 1:S83-S86